Source: Eur Respir J 2016; 48: 619-622
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
José Ricardo J., Brown Jeremy S.. Predicting bacteraemia or rapid identification of the causative pathogen in community acquired pneumonia: where should the priority lie?. Eur Respir J 2016; 48: 619-622

Member's Comments

No comment yet.

Related content which might interest you: Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis Source: Eur Respir J 2015; 45: 1353-1363 Year: 2015 Identifying patients with pneumonia due to MDR organisms coming from the community Source: Eur Respir Monogr 2017; 75: 97-110 Year: 2017 Factors related to obtain an etiological diagnosis in community acquired pneumonia (CAP) Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Resistant pathogens that cause pneumonia: a global perspective Source: International Congress 2014 – Multidrug-resistant (MDR) pathogens that cause pneumonia Year: 2014 Severe community acquired pneumonia: clinical and aetiological evaluation Source: Eur Respir J 2007; 30: Suppl. 51, 673s Year: 2007 Defining, treating and preventing hospital acquired pneumonia: European perspective Source: Guideline 2009 Year: 2009 Treating nosocomial pneumonia: what's new Source: ERJ Open Res, 4 (2) 00058-2018; 10.1183/23120541.00058-2018 Year: 2018 Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia Source: Eur Respir J 2009; 33: 394-400 Year: 2009 Healthcare-associated pneumonia among hospitalized patients. Is it really different from community acquired pneumonia? Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Actual problem in childhood - community acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005 Poor prediction of potentially drug-resistant pathogens using current criteria of health care-associated pneumonia Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Healthcare associated pneumonia does not accurately identify potentially resistant pathogens: A systematic evaluation Source: Annual Congress 2013 –Interesting research questions Year: 2013 Defining stability in pneumonia and the non-responding pneumonia Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005 Can sputum induction aid in identifying micro-organisms that cause respiratory tract infections other than tuberculosis? A tertiary care hospital experience. Source: Virtual Congress 2021 – Pneumonia Year: 2021 Non-tuberculous mycobacterial disease in patients who were referred as MDR-TB in resource limited settings: need for more rapid identification Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 Validation of a computer predictive model to stratify risk and site of care in community acquired pneumonia (CAP) Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 Is health care-associated pneumonia itself a predisposing factor for multi-drug resistant organisms? Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019